<DOC>
	<DOC>NCT00578448</DOC>
	<brief_summary>The purpose of this study is to assess the pharmacokinetics and safety of belatacept in de novo renal transplant subjects treated with belatacept-based immunosuppressant medication</brief_summary>
	<brief_title>Belatacept Pharmacokinetic Trial in Renal Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Abatacept</mesh_term>
	<criteria>Recipient of a living or deceased donor kidney First or second transplant Men and women, including women of childbearing potential, 18 years and older Panel reactive antibodies â‰¥ 30% Significant infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>